CVRx
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Minnesota, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9201 W Broadway Ave Ste 650, Minneapolis...Phone Number
(763) 416-2840Website
www.cvrx.comRevenue
$61.2 MillionStock Symbol
CVRXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Explore more
CVRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CVRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CVRx recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at CVRx
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if CVRx is spiking on competitors!
Product Launch: Get notified when CVRx launches new products
Funding: Get notified immidiatlly once CVRx has new funding data
Click to see if CVRx had a recent Job posting/layoffs
CVRx, which may be a good buyer, showed buying intent in Masked Content Topic
Check if CVRx has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined CVRx as Masked Content
Find more new buyers
Compare Similar Companies to CVRx
Compare insights from companies similar to CVRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CVRx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CVRx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CVRx.
CVRx financials insights
Gather financial insights about CVRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series C
$30.1M
2007
Series D
$65M
2008
Series A
$84M
2013
Private Equity
$29.6M
Series F
$12M
2014
Debt
$15M
2016
Multiple Rounds
$170.7M
2020
Other Financing Round
$50M
CVRx Tech Stack
A closer look at the technologies used by CVRx
Most Recent Scoops
Pain Point
received a civil investigative demand from the U.S. Department of Justice in May 2026 related to certain sales and marketing practices, and the company has stated it is fully cooperating with the investigation.
Compliance, Lawsuits, Legal Affairs
Pain Point
CVRx is experiencing negative implant growth rates year-to-date in regions where tenure is lowest, effectively offsetting strong growth in regions executing the company's strategy.
Pain Point, Employee Relations, Employee Retention, HR Operations
Pain Point
CVRx is facing a significant prior authorization challenge with its largest Medicare Advantage payer, which implemented AI-based prior authorization tools in February that caused the 30-day approval rate to fall from approximately 80% to below 30%, leading some physicians to become more hesitant to recommend Barostim therapy to patients covered under that plan.
Pain Point
Open Position
CVRx is currently seeking a new Chief Financial Officer as part of an ongoing leadership transition.
Executive Moves, Seeking Replacement
Pain Point
Pain Point, Executive Moves, Sales, Employee Relations, Employee Retention, HR Operations
CVRx News & Media
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.CVRx Responds to Letter from Pointillist Family Office
MINNEAPOLIS, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today issued the following statement in response to the public letter to CVRx’s Board of Directors from Jorey Chernett at Pointillist Family Office, dated August 24, 2026:Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer
Delivers Letter to the CVRx Board Highlighting Significant Value Proposition of Barostim to a Large Medical Device Company with Established Infrastructure to Capitalize on the Product's Market Position BLOOMFIELD HILLS, Mich., Aug. 24, 2026 /PRNewswire/ -- Jorey Chernett, Founder of...CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
MINNEAPOLIS, Aug. 24, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Devoted Health has issued a Medicare Advantage coverage policy for Barostim therapy, effective July 17, 2026. Devoted Health, a national health insurance company with the eighth largest Medicare Advantage enrollment i
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CVRx
Sign Up For FreeTo access detailed company insights
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart fai... Read More
